Obesity (Silver Spring, Md.)
The Uncharted Territory of the New Obesity Drugs in Users Without Obesity: A Sociomedical Perspective.
Fernanda Baeza Scagliusi, Bruno Gualano, Pernille Andreassen, Cindi SturtzSreetharan, Sissel Due Jensen, Alexandra Brewis
Published: 202510.1002/oby.70069
Abstract
The off-label use of glucagon-like peptide-1 receptor agonists (GLP-1ra) among people without obesity and/or diabetes is rapidly expanding, despite a lack of clinical justification or safety data in this population. This Perspective explores the soci…
Preview only. Read the full abstract at the source